Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

981
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
981
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Subviral Agents01:29

Subviral Agents

596
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
596
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

49.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.8K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.1K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.1K
Retroviruses02:33

Retroviruses

15.0K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
15.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis C virus.

Postgraduate medicine·2017
Same journal

CV risk: if you aren't testing ACR, you aren't seeing the full picture.

Postgraduate medicine·2026
Same journal

Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

Postgraduate medicine·2026
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 17, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.3K

Viral hepatitis.

Paul R Becherer

    Postgraduate Medicine
    |December 12, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Viral hepatitis incidence remains stable in the US, but changing risk factors due to human behavior require updated screening strategies. This review examines the evolution of viral hepatitis epidemiology and its impact on serologic testing.

    More Related Videos

    Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
    11:14

    Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

    Published on: November 7, 2018

    18.9K
    "Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
    10:25

    "Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

    Published on: February 19, 2019

    12.2K

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
    10:28

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

    Published on: June 26, 2020

    10.3K
    Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
    11:14

    Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

    Published on: November 7, 2018

    18.9K
    "Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
    10:25

    "Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

    Published on: February 19, 2019

    12.2K

    Area of Science:

    • Epidemiology
    • Public Health
    • Infectious Diseases

    Background:

    • Viral hepatitis incidence in the US has been consistent for decades.
    • Vaccines, prophylaxis, and sanitation have not significantly altered overall incidence.
    • However, epidemiologic factors and risk behaviors are evolving.

    Purpose of the Study:

    • To discuss the changing landscape of viral hepatitis.
    • To analyze the impact of evolving epidemiology on serologic screening.

    Main Methods:

    • Review of existing epidemiologic data on viral hepatitis.
    • Analysis of behavioral and ecological factors influencing disease transmission.
    • Evaluation of current serologic screening protocols.

    Main Results:

    • Despite stable incidence, risk factors for viral hepatitis acquisition are shifting.
    • Changes in human ecology and behavior are primary drivers of these shifts.
    • Current screening may need adjustments to reflect these changes.

    Conclusions:

    • The evolution of viral hepatitis epidemiology necessitates a re-evaluation of screening practices.
    • Adapting serologic screening is crucial for effective public health management.
    • Understanding changing risk factors is key to controlling viral hepatitis.